AusTrials
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
AusTrials - overview
Established
2008
Location
Taringa, QLD, Australia
Primary Industry
Pharmaceuticals
About
Founded in 2008 and based in Queensland, Australia, Data Health Australia Pty Ltd, trading as AusTrials, operates as a provider of clinical trial site management organizations to research organizations and pharmaceutical companies. In July 2023, P3 Research Ltd. , a portfolio company of Genesis Capital, acquired AusTrials. The company is a clinical research provider with a primary focus on delivering phase II–IV interventional studies, collecting practical evidence, and conducting observational research in realistic clinical settings.
Clinical trials are conducted in a variety of areas, including infections, pain treatment, heart disease, diabetes, obesity, mental health, and autoimmune diseases. AusTrials conducts both interventional and observational research and collaborates with pharmaceutical firms, contract research organizations, and academic research institutes to provide patients with access to clinical trials.
Current Investors
Momentum Clinical Research
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.austrials.com.au
Company Stage
Add-on
Total Amount Raised
Subscriber access only
AusTrials - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | AusTrials | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.